The ViroGates share has shown strong performance with an increase of almost 100% this year (November 5, 2021), driven by customer progress, solid clinical sales
ViroGates is an international medical technology company working with suPAR, which is a biomarker that detects inflammation in the body. It is possible to measure
Kapital Partner A/S
Christian IX's Gade 10, 4. th
1111 København K
CVR: 37364843
Kapital Partner performs or has within the last 12 months performed corporate finance, market relations, investor relations, Certified Adviser or other advisory activities for the following listed companies: NORD.investments, Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.
Del indlægget på sociale media eller på email.